November 29, 2018
Mylan has a strong and distinct focus on fighting infectious disease. So we’re turning our logo red this week in commemoration of World AIDS Day on Dec. 1 and to reflect our long-standing commitment to increase access to treatment addressing some of the world’s most significant public health issues.
We believe everyone deserves the opportunity to live a healthy life, especially when it comes to battling HIV/AIDS. We’ve invested more than $250 million to expand antiretroviral (ARV) production capacity, and we now manufacture more than 4 billion ARV tablets each year. The result: More than 8 million people, about 40% of all patients on HIV treatment worldwide, depend on a Mylan ARV every day.
The Mylan ARV Story
The Mylan ARV Fact Sheet
CEO Heather Bresch's blog